top of page
  • Rick

FDA Alert of Dental Complications




As of January 10th, 2022, the FDA has issued a warning that "dental problems" could result from the use of buprenorphine medicines dissolved intra-orally. If you have patients with a history of opioid abuse, transmucosal use of buprenorphine can affect their oral health and should enter into your treatment plans.


For further information, see the drug-use guide on the FDA's web site or view the entire FDA alert here.



11 views

Recent Posts

See All

Arm Yourself with the Power of Knowledge

Infection control has been receiving a lot of extra attention of late, but it has always been a concern in dental offices. There have...

Is This an OSHA Violation?

A discussion of what agency covers what regulations. Helping navigate the various federal agencies.

Komentarai


bottom of page